PTC Therapeutics | PTCT - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
Amgen USD 1.6B 187M 2026-03
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Biogen USD 797.5M 302M 2026-03
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Cytokinetics USD 160K 104.24M 2026-03
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Gilead Sciences USD 1.44B 174M 2026-03
Incyte USD 104.5M 16.68M 2026-03
Ionis Pharmaceuticals USD 3M 5M 2026-03
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Roche Holding CHF 8.48B 4.61B 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
TG Therapeutics USD 33.51M 4.63M 2026-03
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03
Xencor USD 61.66M 50.95M 2025-06